U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C4H5NO4.Cu
Molecular Weight 194.633
Optical Activity UNSPECIFIED
Defined Stereocenters 1 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of COPPER ASPARTATE

SMILES

[Cu++].N[C@@H](CC([O-])=O)C([O-])=O

InChI

InChIKey=LHBCBDOIAVIYJI-DKWTVANSSA-L
InChI=1S/C4H7NO4.Cu/c5-2(4(8)9)1-3(6)7;/h2H,1,5H2,(H,6,7)(H,8,9);/q;+2/p-2/t2-;/m0./s1

HIDE SMILES / InChI

Molecular Formula Cu
Molecular Weight 63.546
Charge 2
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Molecular Formula C4H5NO4
Molecular Weight 131.0868
Charge -2
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 1 / 1
E/Z Centers 0
Optical Activity UNSPECIFIED

Description
Sources: DOI: 10.2903/j.efsa.2008.883
Curator's Comment: description was created based on several sources, including: https://www.fda.gov/ohrms/dockets/dailys/04/nov04/112904/97s-0162-let14852-vol130.pdf | http://www.naturesoasismarket.com/ns/DisplayMonograph.asp?StoreID=0E75F5E3C2DF416C896EF03680134ECB&DocID=bottomline-asparticacid | https://www.vitaminmineralshop.com/copper.php

Copper aspartate is intended to be used as sources for copper in food supplements. Aspartates are taken by mouth to increase the absorption of mineral supplements. Studies have linked copper deficiencies to heart disease via elevated LDL ("bad") cholesterol levels and the lowering of HDL ("good") cholesterol. There's also a link to copper deficiencies and high blood pressure. One of the early signs of copper deficiency is osteoporosis. Other signs of deficiency of copper include: anemia, skin sores, diarrhea, baldness, skeletal deformities, impaired respiratory function, loss of skin color, general weakness, and nerve degeneration.

Approval Year

Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Sources: DOI: 10.2903/j.efsa.2008.883
Primary
Unknown

Approved Use

Unknown
Patents

Sample Use Guides

In Vivo Use Guide
Sources: DOI: 10.2903/j.efsa.2008.883
10.3 mg daily
Route of Administration: Oral
In Vitro Use Guide
Unknown
Substance Class Chemical
Created
by admin
on Sat Dec 16 01:38:54 UTC 2023
Edited
by admin
on Sat Dec 16 01:38:54 UTC 2023
Record UNII
Y2Q0CK9869
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
COPPER ASPARTATE
INCI  
INCI  
Official Name English
L-ASPARTIC ACID, COPPER(2+) SALT (1:1)
Common Name English
L-ASPARTIC ACID, COPPER(2+) SALT
Common Name English
COPPER, (L-ASPARTATO)-
Common Name English
COPPER L-ASPARTATE
Systematic Name English
COPPER, (L-ASPARTATO(2-)-.KAPPA.N,.KAPPA.O1,.KAPPA.O4)-
Common Name English
COPPER ASPARTATE [INCI]
Common Name English
Code System Code Type Description
FDA UNII
Y2Q0CK9869
Created by admin on Sat Dec 16 01:38:54 UTC 2023 , Edited by admin on Sat Dec 16 01:38:54 UTC 2023
PRIMARY
CAS
30272-90-3
Created by admin on Sat Dec 16 01:38:54 UTC 2023 , Edited by admin on Sat Dec 16 01:38:54 UTC 2023
PRIMARY
PUBCHEM
10420163
Created by admin on Sat Dec 16 01:38:54 UTC 2023 , Edited by admin on Sat Dec 16 01:38:54 UTC 2023
PRIMARY
EPA CompTox
DTXSID90184363
Created by admin on Sat Dec 16 01:38:54 UTC 2023 , Edited by admin on Sat Dec 16 01:38:54 UTC 2023
PRIMARY
SMS_ID
100000079824
Created by admin on Sat Dec 16 01:38:54 UTC 2023 , Edited by admin on Sat Dec 16 01:38:54 UTC 2023
PRIMARY
Related Record Type Details
PARENT -> SALT/SOLVATE
PARENT -> SALT/SOLVATE